Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines

Moderna Today Moderna -5.20 (-3.58%) ▼ Price Target $129.02 Biotechnology firm Moderna Inc. NASDAQ: MNRA made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA (mRNA) technology for the development of innovative treatments. The company continues expanding its treatments for various diseases and illnesses, including cardiovascular disease, cancer, and other rare diseases. Moderna has been working on personalized cancer vaccines that will enable a cancer p ...